Literature DB >> 21467018

Adult survivors of invasive pneumococcal disease exhibit defective B cell function.

Tom C Darton1, James B Wing, Andrew Lees, Andrew W Heath, Robert C Read.   

Abstract

Adults who have recovered from an episode of invasive pneumococcal disease demonstrate defective B cell activation in response to αδ-dex, a polyclonal polysaccharide mimic, compared with matched control subjects. The defect is not overcome by CD4(+) T cell assistance and may explain the relatively poor response to pneumococcal vaccination in survivors of invasive pneumococcal disease.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21467018      PMCID： PMC3106266          DOI： 10.1093/cid/cir126

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  14 in total

1.  Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-09-03       Impact factor: 17.586

2.  Homozygosity for the IgG2 subclass allotype G2M(n) protects against severe infection in hereditary C2 deficiency.

Authors:  Göran Jönsson; Vivi-Anne Oxelius; Lennart Truedsson; Jean Henrik Braconier; Gunnar Sturfelt; Anders G Sjöholm
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

3.  IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.

Authors:  Cheng-Lung Ku; Capucine Picard; Melinda Erdös; Axel Jeurissen; Jacinta Bustamante; Anne Puel; Horst von Bernuth; Orchidée Filipe-Santos; Huey-Hsuan Chang; Tatiana Lawrence; Marc Raes; László Maródi; Xavier Bossuyt; Jean-Laurent Casanova
Journal:  J Med Genet       Date:  2006-09-01       Impact factor: 6.318

Review 4.  Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis.

Authors:  Meenakshi Ramakrishnan; Jennifer C Moïsi; Keith P Klugman; Jesus M Feris Iglesias; Lindsay R Grant; Mireille Mpoudi-Etame; Orin S Levine
Journal:  Lancet Infect Dis       Date:  2010-05       Impact factor: 25.071

Review 5.  Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?

Authors:  Katherine L O'Brien; Michael Hochman; David Goldblatt
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

6.  Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID).

Authors:  C Groth; R Drager; K Warnatz; G Wolff-Vorbeck; S Schmidt; H Eibel; M Schlesier; H-H Peter
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

7.  Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.

Authors:  Eugene V Millar; James P Watt; Melinda A Bronsdon; Jean Dallas; Raymond Reid; Mathuram Santosham; Katherine L O'Brien
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

8.  Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.

Authors:  Daniel M Musher; Adriana M Rueda; Moon H Nahm; Edward A Graviss; Maria C Rodriguez-Barradas
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

9.  Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal disease.

Authors:  Ray Borrow; Elaine Stanford; Pauline Waight; Matthew Helbert; Paul Balmer; Rosalind Warrington; Mary Slack; Robert George; Elizabeth Miller
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

10.  Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens.

Authors:  C M Snapper; T M McIntyre; R Mandler; L M Pecanha; F D Finkelman; A Lees; J J Mond
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307
View more
  4 in total

1.  Contact dependent suppression of CD4 T cell activation and proliferation by B cells activated through IgD cross-linking.

Authors:  Lorena Preciado-Llanes; James B Wing; Rachel A Foster; Jennifer Carlring; Andrew Lees; Robert C Read; Andrew W Heath
Journal:  Immunology       Date:  2014-09-20       Impact factor: 7.397

2.  Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.

Authors:  James B Wing; Lynne Smart; Ray Borrow; Jamie Findlow; Helen Findlow; Andrew Lees; Rachel A Foster; Jennifer Carlring; Robert C Read; Andrew W Heath
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

Review 3.  Role of circulating lymphocytes in patients with sepsis.

Authors:  Raul de Pablo; Jorge Monserrat; Alfredo Prieto; Melchor Alvarez-Mon
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

4.  Early alterations of B cells in patients with septic shock.

Authors:  Jorge Monserrat; Raul de Pablo; David Diaz-Martín; Manuel Rodríguez-Zapata; Antonio de la Hera; Alfredo Prieto; Melchor Alvarez-Mon
Journal:  Crit Care       Date:  2013-05-30       Impact factor: 9.097
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.